IVZ media thread, page-6094

First 6094 Last

Share
Profile

Follow
Portiss

1,130 Posts.

1647

14/03/24

19:44

Post #: 72893140
Share

Originally posted by onthepunt: ↑

Managed to have a decent text conversation with Scott just now and he was good enough to give me a fair bit of time. Will summarise below. DYOR etc. etc.

OTP- Hi Scott, hope you're going well and ignoring hot copper
Hoping the financing can get taken care of without another PAC raise.
Are you able to comment on the status of SG4571? Exploration license expiry this June?

SM- I never go into the cesspit! ….
As with every licence there is an expiry date. We have fulfilled all our commitments and licence will be renewed. This is catered for in Mines and Minerals Act and the PEDPA executed in 2021. We have already had it renewed in 2021. They are 3 year terms
On funding as per yesterday Ann there is substantial interest from local investors and that is being coordinated by Mangwana and will be settled in short term. They are term holders that see the strategic importance and value of our assets, and also potential partners waiting on PPSA execution. None of it happens overnight but we always deliver

OTP- Also, just curious if you or the other directors are taking any of the rights or shortfall? Or if you are eligible with blackouts etc.?

SM- Shortfall

OTP- Great. I think that will help sentiment a lot. Is that still running for the 3 months? Are you allowed to announce you have applied?

SM- Can place shortfall up to 3 months from close. And yes can announce once applied as will require approval

OTP- Cheers. I know you’re still planning and contracting for well testing. Still looking at Q2 or more likely Q3 now?
Sorry if I’m asking too many questions

SM- Will provide timing once design and procurement and contacting done
Also. The lifting of sanctions on Zimbabwe by the US last week and calls in UK for similar review to lift them and the timing of our discovery is a remarkable coincidence

OTP- No such thing as coincidences?
Sanctions now on certain people instead of the country I believe. Do you see that as beneficial for the nation and IVZ?

SM- Of course. Zim allowed back onto the SWIFT banking system and multi lateral lenders and large instos

OTP- Like you say, excellent timing

Expand

the fact that Scott is talking about the lifting of Sanctions makes me wonder…. Is his cheeky statement about coincidences indicative of Partners/TO/Funding/Banks from US or UK?

IVZ Price at posting: 8.7¢ Sentiment: Buy Disclosure: Held
22 Upvote

1 Great analysis

Reply

Top Stories

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 1,564 more messages in this thread...

First 6094 Last

Add IVZ (ASX) to my watchlist

(20min delay)
Last 7.7¢		Change 0.000(0.00%)		Mkt cap ! $116.7M

Open	High	Low	Value	Volume
7.5¢	7.7¢	7.4¢	$74.12K	990.8K

Buyers (Bids)

No.	Vol.	Price($)
2	56930	7.4¢

Sellers (Offers)

Price($)	Vol.	No.
7.7¢	12986	1

View Market Depth

No.	Vol.	Price($)
2	56930	0.074
2	39931	0.073
3	84432	0.072
3	89050	0.071
5	396817	0.070

Price($)	Vol.	No.
0.077	12986	1
0.078	254968	4
0.080	153368	5
0.081	1000	1
0.082	72100	1

Last trade - 16.10pm 07/10/2024 (20 minute delay)

IVZ (ASX) Chart

IVZ media thread, page-6094

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

IVZ media thread, page-6094

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News